Sackler Family’s Role in Opioid Crisis Revealed
The Sacklers had a new plan.
It was 2014, and the company the family had controlled for two generations, Purdue Pharma, had been hit with years of investigations and lawsuits over its marketing of the highly addictive opioid painkiller OxyContin, at one point pleading guilty to a federal felony and paying more than $600 million in criminal and civil penalties.
But as the country’s addiction crisis worsened, the Sacklers spied another business opportunity. They could increase their profits by selling treatments for the very problem their company had helped to create: addiction to opioids.
Details of the effort, named Project Tango, have come to light in lawsuits filed by the attorneys general of Massachusetts and New York.
TriMark Legal Funding provides non-recourse pre settlement lawsuit funding and post settlement loans to injured plaintiffs nationwide. Call (877) 932-2628 with questions or to apply for funding.
This post originally appeared here: https://www.nytimes.com/2019/04/01/health/sacklers-oxycontin-lawsuits.html
Click here to see the full original article.